Health Care

What Analyst Recommend Mean Price Target for Stock? Bristol-Myers Squibb Company (NYSE:BMY)

0 7

Bristol-Myers Squibb Company (NYSE:BMY) dropped -0.66% and closed the trade at $ 55.60. The company recorded a trading capacity of 12.08 million shares above its three months average daily volume of 10.84 million shares. During the last trade, shares reached to high price of $56.41 and touched the low price of $55.53. The stock’s 50-day moving average is noted at $62.43 and its 200-day moving average is stands at $67.98.

Additionally, the company has a PE ratio of 32.51 and has EPS of 1.71. The company has market capitalization of $92.90B.

Currently Bristol-Myers Squibb Company (BMY) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “10″ Analysts”. “1” rated “Sell” for the company. “13” said the company as a “Hold”. Overweight rating was given by “1” and Underweight rating was given by “1”.

Analysts are expecting that the company to achieve $68.46 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $100.00 however minimum price target advised by analysts is $50.00. The Median price target for the stock is measured at $66.50.

Presently, Analysts decided consensus EPS estimate of $0.64 for present quarter and one month ago projected EPS estimate was at $0.64. If we take a look at back 3 month ago, consensus EPS estimate was $0.64.

A current consensus EPS estimate for next quarter is at $0.56 and 3 month ago EPS forecast was $0.57. Have a look at back 1 month ago, consensus EPS forecast was seen at $0.57.

For current fiscal year, most recent EPS estimate is set at $2.62 based on Analyst consensus and three month ago consensus EPS opinions was at $2.55. During period one month ago, consensus EPS forecast was decided at $2.61.

A current consensus EPS projection for next fiscal year is observed at $3.01 and one month ago consensus EPS forecast was at $3.03. Take a look at back three month ago, consensus EPS estimate opinions was decided at $3.23 by analysts.

One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 10 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 1. 13 advised the “Hold” rating about this stock. 1 revealed “Sell” signal and “Underweight” rating was declared by 1.

Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 13 said a “Buy Rating” and 1 announced “Overweight Rating”. 11 advised “Hold Rating” regarding the stock. 1 announced “Sell Rating” and 1 disclosed “Underweight Rating”.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.